Cagrilintide 10mg

$149.99

(5.0) (55 customer reviews)

Long-acting amylin analog in active obesity and cardiometabolic programs

Quantity:

Free Shipping
Interac e-Transfer ordering: Add the product to your cart, submit your shipping details at checkout, and wait for the order confirmation email before sending payment.

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.

Description

Cagrilintide is a long-acting amylin analog with published obesity and diabetes trial data, including combination development programs with semaglutide.

What it is

Cagrilintide is a long-acting amylin analog in active metabolic-disease development, with published obesity/diabetes trial data and ongoing late-stage programs.

Mechanism snapshot

  • Targets amylin-pathway signaling involved in appetite and energy-balance regulation.
  • Investigated as monotherapy and in coadministration with semaglutide (CagriSema) for weight and glycemic endpoints.
  • Studied for efficacy durability, tolerability, and cardiometabolic-risk impact.

Research programs

  • Phase 1b and phase 2 weight-management trials.
  • Late-stage registry programs in obesity and type 2 diabetes populations.
  • Comparative and long-horizon maintenance-of-effect investigations.

Limitations

  • Full late-stage synthesis is still evolving and status can change.
  • Comparative efficacy interpretation depends on protocol and population context.
  • Long-term safety and indication-specific labeling remain development-dependent.

Selected references

Ordering

Add this item to your cart, submit your shipping details at checkout, and wait for your order confirmation. Interac e-Transfer instructions are sent after the order request is received.

Additional information

Catalog category

Metabolic & Weight‑Management

Source category

Metabolic Peptides

Composition

Cagrilintide 10 mg

Research status

late-stage

Regulatory

Late-stage investigational status; trial registry and sponsor updates should be checked for current program state.

Research note

Trial and development status should be validated against current registry and sponsor updates.

Keywords

10mg, appetite, appetiteregulation, body, cagrilintide, composition, fat, glucose, loss, management, metabolic, peptide, weight

Have Questions?

Our team is ready to assist you with any inquiries regarding our catalogue of peptides and their applications.

Okanagan Peptides Logo with Black Letters
0